Top VA pharmaceutical preparation manufacturing contractors (NAICS 325412)
- Latest 12 months
- $12.3B
- Net obligations · Up $623.2M vs. $11.7B preceding
- Prime contractors
- 158
- With positive obligations in the latest 12 months
Research the VA federal contracting market for pharmaceutical preparation manufacturing under NAICS 325412. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.
Contract obligation trends for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs
Federal records show $50.5B in net obligations across 6,560 awards in Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Sep 10, 2026. This market accounts for 14.9% of $339.1B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 5.3% from $11.7B to $12.3B. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $8.3B | 2,193 | Complete |
| FY2023 | $9.4B | 2,088 | Complete |
| FY2024 | $8.8B | 2,417 | Complete |
| FY2025 | $11.7B | 2,089 | Complete |
| FY2026 | $12.3B | 1,944 | YTD through Sep 10, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $50.5B
- 6,560 awards · 355 prime contractors
- Latest 12-month movement
- +5.3%
- $12.3B vs. $11.7B
- Leading eight prime share
- 99.4%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 14.9% of $339.1B in agency-wide net obligations.
- Set-aside share when reported
- 33.5% of 2,516 awards with reported set-aside status.
- Set-aside reporting
- 843 set aside · 1,673 no set-aside · 4,044 not reported
What changed in the last 12 months?
Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.
Market structure
Award activity
MCKESSON CORPORATION received an unusually large obligation action
Competitive shifts
EXELAN PHARMACEUTICALS INC climbed the most in the contractor rankings
MCKESSON CORPORATION had the largest increase in reported obligations
Buyer demand
Reported obligations through VHA CHIEF LOGISTICS OFFICE (36C240) increased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.
97.7% of positive obligations were attributed to VHA CHIEF LOGISTICS OFFICE (36C240). That represents $12.0B, up $551.8M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- VHA CHIEF LOGISTICS OFFICE (36C240)97.7% · $12.0B · up $551.8M
- 242-NETWORK CONTRACT OFFICE 02 (36C242)0.090% · $10.6M · up $6.5M
- 541-BRECKSVILLE (00541)0.080% · $10.2M · up $5.6M
- 691-VA GREATER LA HLTHCR SYS(00691)0.080% · $10.2M · up $3.0M
- 549-DALLAS (00549)0.070% · $8.0M · up $1.1M
- All other reported offices2.0% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
VHA CHIEF LOGISTICS OFFICE (36C240)
#1Rank unchangedLatest 12 months
$12.0B
97.7% of positive obligations
Versus preceding 12 months
+$551.8M
1 active prime contractor · 10 awards
View office comparison and evidence
Reported obligations increased 4.8% from $11.4B to $12.0B. The office’s share of positive obligations moved from 98.1% to 97.7%, a change of −0.5 percentage points.
The latest period contains 10 actions across 10 awards. The preceding period contained 1 active prime contractor and 12 awards.
Leading award-level changes
- MCKESSON CORPORATION · PIID 36C24026K1002+$1.4B: $0 → $1.4B
- MCKESSON CORPORATION · PIID 36C24026K1008+$1.4B: $0 → $1.4B
Reported funding office
242-NETWORK CONTRACT OFFICE 02 (36C242)
#2Up 14 from #16Latest 12 months
$10.6M
0.090% of positive obligations
Versus preceding 12 months
+$6.5M
9 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations increased 161.9% from $4.0M to $10.6M. The office’s share of positive obligations moved from 0.030% to 0.090%, a change of +0.1 percentage points.
The latest period contains 23 actions across 15 awards and 4 newly active prime contractors. The preceding period contained 8 active prime contractors and 16 awards.
Reported funding office
541-BRECKSVILLE (00541)
#3Up 9 from #12Latest 12 months
$10.2M
0.080% of positive obligations
Versus preceding 12 months
+$5.6M
15 active prime contractors · 28 awards
View office comparison and evidence
Reported obligations increased 122.2% from $4.6M to $10.2M. The office’s share of positive obligations moved from 0.040% to 0.080%, a change of 0.0 percentage points.
The latest period contains 38 actions across 28 awards and 7 newly active prime contractors. The preceding period contained 10 active prime contractors and 17 awards.
Reported funding office
691-VA GREATER LA HLTHCR SYS(00691)
#4Up 1 from #5Latest 12 months
$10.2M
0.080% of positive obligations
Versus preceding 12 months
+$3.0M
15 active prime contractors · 23 awards
View office comparison and evidence
Reported obligations increased 41.0% from $7.2M to $10.2M. The office’s share of positive obligations moved from 0.060% to 0.080%, a change of 0.0 percentage points.
The latest period contains 34 actions across 23 awards and 3 newly active prime contractors. The preceding period contained 15 active prime contractors and 22 awards.
Reported funding office
549-DALLAS (00549)
#5Up 1 from #6Latest 12 months
$8.0M
0.070% of positive obligations
Versus preceding 12 months
+$1.1M
11 active prime contractors · 26 awards
View office comparison and evidence
Reported obligations increased 15.4% from $6.9M to $8.0M. The office’s share of positive obligations moved from 0.060% to 0.070%, a change of 0.0 percentage points.
The latest period contains 40 actions across 26 awards and 1 newly active prime contractor. The preceding period contained 12 active prime contractors and 23 awards.
Reported funding office
578-HINES(00578)(36C578)
#6Up 9 from #15Latest 12 months
$7.5M
0.060% of positive obligations
Versus preceding 12 months
+$3.5M
14 active prime contractors · 22 awards
View office comparison and evidence
Reported obligations increased 85.2% from $4.1M to $7.5M. The office’s share of positive obligations moved from 0.030% to 0.060%, a change of 0.0 percentage points.
The latest period contains 32 actions across 22 awards and 5 newly active prime contractors. The preceding period contained 11 active prime contractors and 25 awards.
Reported funding office
261-NETWORK CONTRACT OFFICE 21 (36C261)
#7Up 37 from #44Latest 12 months
$7.4M
0.060% of positive obligations
Versus preceding 12 months
+$5.8M
32 active prime contractors · 69 awards
View office comparison and evidence
Reported obligations increased 361.0% from $1.6M to $7.4M. The office’s share of positive obligations moved from 0.010% to 0.060%, a change of +0.1 percentage points.
The latest period contains 89 actions across 69 awards and 9 newly active prime contractors. The preceding period contained 31 active prime contractors and 69 awards.
Reported funding office
626-NASHVILLE (00626)
#8Down 5 from #3Latest 12 months
$7.1M
0.060% of positive obligations
Versus preceding 12 months
−$2.7M
10 active prime contractors · 36 awards
View office comparison and evidence
Reported obligations decreased 27.7% from $9.8M to $7.1M. The office’s share of positive obligations moved from 0.080% to 0.060%, a change of 0.0 percentage points.
The latest period contains 40 actions across 36 awards and 3 newly active prime contractors. The preceding period contained 13 active prime contractors and 53 awards.
Reported funding office
VETERANS HEALTH ADMINISTRATION
#9Up 33 from #42Latest 12 months
$6.3M
0.050% of positive obligations
Versus preceding 12 months
+$4.5M
6 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations increased 248.9% from $1.8M to $6.3M. The office’s share of positive obligations moved from 0.020% to 0.050%, a change of 0.0 percentage points.
The latest period contains 8 actions across 7 awards and 4 newly active prime contractors. The preceding period contained 4 active prime contractors and 8 awards.
Reported funding office
659-SALISBURY (00659)(36C659)
#10Up 33 from #43Latest 12 months
$6.2M
0.050% of positive obligations
Versus preceding 12 months
+$4.5M
6 active prime contractors · 11 awards
View office comparison and evidence
Reported obligations increased 253.6% from $1.8M to $6.2M. The office’s share of positive obligations moved from 0.020% to 0.050%, a change of 0.0 percentage points.
The latest period contains 12 actions across 11 awards and 3 newly active prime contractors. The preceding period contained 3 active prime contractors and 5 awards.
Reported funding office
NATIONAL CMOP OFFICE (36C770)
#11Down 9 from #2Latest 12 months
$6.0M
0.050% of positive obligations
Versus preceding 12 months
−$10.9M
13 active prime contractors · 18 awards
View office comparison and evidence
Reported obligations decreased 64.4% from $16.9M to $6.0M. The office’s share of positive obligations moved from 0.14% to 0.050%, a change of −0.1 percentage points.
The latest period contains 23 actions across 18 awards and 3 newly active prime contractors. The preceding period contained 24 active prime contractors and 67 awards.
Leading award-level changes
- NATIONWIDE PHARMACEUTICAL LLC · PIID 36C77025P0031−$2.6M: $2.6M → $0
- SHABACH SERVICES LLC · PIID 36C77025P0020−$2.4M: $2.4M → $0
Reported funding office
521-BIRMINGHAM(00521)(36C521)
#12New to the positive-obligation rankingLatest 12 months
$6.0M
0.050% of positive obligations
Versus preceding 12 months
+$6.4M
5 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations moved from $384K in net deobligations to $6.0M in net obligations. The office’s share of positive obligations moved from 0% to 0.050%, a change of +0.1 percentage points.
The latest period contains 15 actions across 5 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 5 awards.
Reported funding office
548-WEST PALM (00548)(36C548)
#45Down 36 from #9Latest 12 months
$2.7M
0.020% of positive obligations
Versus preceding 12 months
−$3.9M
5 active prime contractors · 13 awards
View office comparison and evidence
Reported obligations decreased 59.0% from $6.6M to $2.7M. The office’s share of positive obligations moved from 0.060% to 0.020%, a change of 0.0 percentage points.
The latest period contains 18 actions across 13 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 15 awards.
Reported funding office
VA CMOP TUCSON (00762)
#80Down 76 from #4Latest 12 months
$1.0M
0.010% of positive obligations
Versus preceding 12 months
−$7.4M
9 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations decreased 87.6% from $8.5M to $1.0M. The office’s share of positive obligations moved from 0.070% to 0.010%, a change of −0.1 percentage points.
The latest period contains 15 actions across 14 awards and 2 newly active prime contractors. The preceding period contained 13 active prime contractors and 26 awards.
Reported funding office
NAC PHARMACEUTICALS (36E797)
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$6.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $6.8M to $0. The office’s share of positive obligations moved from 0.060% to 0%, a change of −0.1 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 34 awards.
Reported funding office
580-HOUSTON(00580)
No positive-obligation rankLatest 12 months
−$423K
0% of positive obligations
Versus preceding 12 months
−$7.3M
8 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations moved from $6.9M in net obligations to $423K in net deobligations. The office’s share of positive obligations moved from 0.060% to 0%, a change of −0.1 percentage points.
The latest period contains 25 actions across 14 awards. The preceding period contained 12 active prime contractors and 17 awards.
Contract types, competition, and procurement methods
From Sep 11, 2025 through Sep 10, 2026, 1,118 awards had positive obligations totaling $12.3B. Negotiated Proposal/Quote was the leading reported procedure, accounting for 87.8% of positive obligations. Awards with a reported parent IDV accounted for 99.6%. Reported awards used contract vehicles such as VA FSS Schedule 65IB.
- Leading award type
- 99.2%
- Delivery Order
- Leading reported procedure
- 87.8%
- Negotiated Proposal/Quote
- Reported parent IDV
- 99.6%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 821 of 1,118 awards reported offers
Observed contract vehicles
Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.
- VA FSS Schedule 65IB
$10.5M
0.080% of positive obligations · 66 matched awards
Buying method changes
Compared with Sep 11, 2024–Sep 10, 2025. Based on 1,118 current awards and 1,259 preceding awards with positive net obligations.
- Negotiated Proposal/Quote obligation share
- 87.8%
- Down from 98.0% in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325412 peer median, parent-IDV obligation share is 16.7 percentage points higher, reported full-and-open obligation share is 52.3 percentage points higher, delivery-order obligation share is 19.7 percentage points higher, and median positive award obligations are 478.6% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 99.6% | 82.9% | +16.7 pts |
| Reported full-and-open obligation share | 89.2% | 37.0% | +52.3 pts |
| Delivery-order obligation share | 99.2% | 79.5% | +19.7 pts |
| Median positive award obligations | $65K | $11K | +478.6% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 702 | $12.2B | 99.2% |
| Purchase Order(B) | 303 | $51.2M | 0.41% |
| BPA Call(A) | 100 | $44.0M | 0.36% |
| Definitive Contract(D) | 13 | $3.3M | 0.030% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 224 | $12.1B | 97.8% |
| FSS(C) | 478 | $169.1M | 1.4% |
| BPA(E) | 100 | $44.0M | 0.36% |
| Not reported | 316 | $54.5M | 0.44% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 317 | $12.1B | 98.1% |
| Multiple Award(M) | 485 | $176.9M | 1.4% |
| Not reported | 316 | $54.5M | 0.44% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 67 | $10.8B | 87.8% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 4 | $1.2B | 9.7% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 527 | $193.4M | 1.6% |
| Simplified Acquisition(SP1) | 305 | $73.0M | 0.59% |
| Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY) | 36 | $21.0M | 0.17% |
| Only One Source(SSS) | 117 | $15.5M | 0.13% |
| Other reported values | 62 | $12.8M | 0.10% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full and Open Competition(A) | 580 | $11.0B | 89.2% |
| A(FULL AND OPEN COMPETITION) | 38 | $1.2B | 9.9% |
| Competed Under SAP(F) | 214 | $71.0M | 0.58% |
| Not Competed(C) | 115 | $15.3M | 0.12% |
| Not Competed Under SAP(G) | 96 | $9.0M | 0.070% |
| F(COMPETED UNDER SAP) | 32 | $7.1M | 0.060% |
| Other reported values | 43 | $9.9M | 0.080% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 420 | $115.7M | 0.94% |
| Fair Opportunity Given(FAIR) | 105 | $88.2M | 0.71% |
| Competitive Set Aside(CSA) | 6 | $7.0M | 0.060% |
| Urgency(URG) | 26 | $3.1M | 0.030% |
| Other Statutory Authority(OSA) | 6 | $332K | 0% |
| Not reported | 555 | $12.1B | 98.3% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 119 | $17.7M | 0.14% |
| SAP Non-Competition (FAR 13)(SP2) | 63 | $9.3M | 0.080% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 43 | $2.2M | 0.020% |
| Urgency (FAR 6.302-2)(URG) | 15 | $1.7M | 0.010% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 2 | $60K | 0% |
| Less Than or Equal to the Micro-Purchase Threshold(MPT) | 2 | $5K | 0% |
| Not reported | 874 | $12.3B | 99.7% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 1,014 | $11.1B | 90.0% |
| J(FIRM FIXED PRICE) | 102 | $1.2B | 10.0% |
| Fixed Price with Economic Price Adjustment(K) | 2 | $784K | 0.010% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs and Biologicals(6505) | 1,002 | $12.3B | 99.8% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 25 | $6.3M | 0.050% |
| Pharmacy Services(Q517) | 29 | $6.0M | 0.050% |
| Medical- Nuclear Medicine(Q527) | 13 | $4.8M | 0.040% |
| Imaging Equipment and Supplies: Medical, Dental, Veterinary(6525) | 8 | $2.1M | 0.020% |
| Chemical and Pharmaceutical Products Manufacturing Machinery(3650) | 10 | $1.6M | 0.010% |
| Other reported values | 31 | $4.7M | 0.038% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of Veterans Affairs(3600) | 1,118 | $12.3B | 100.0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Vha Chief Logistics Office (36c240)(36C240) | 10 | $12.0B | 97.3% |
| 262-Network Contract Office 22 (36c262)(36C262) | 80 | $39.7M | 0.32% |
| 246-Network Contracting Office 6 (36c246)(36C246) | 31 | $31.1M | 0.25% |
| 250-Network Contract Office 10 (36c250)(36C250) | 52 | $25.5M | 0.21% |
| 252-Network Contract Office 12 (36c252)(36C252) | 45 | $24.5M | 0.20% |
| 248-Network Contract Office 8 (36c248)(36C248) | 39 | $24.4M | 0.20% |
| Other reported values | 861 | $194.4M | 1.6% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36W79720D0001(3600) | 11 | $12.0B | 97.3% |
| 36F79720D0227(3600) | 51 | $74.0M | 0.60% |
| 36F79720D0180(3600) | 34 | $34.5M | 0.28% |
| 36F79725D0093(3600) | 25 | $20.7M | 0.17% |
| 36C26226A0006(3600) | 8 | $17.5M | 0.14% |
| 36F79724D0101(3600) | 24 | $7.2M | 0.060% |
| 36F79719D0170(3600) | 14 | $7.2M | 0.060% |
| 36C24823D0049(3600) | 3 | $5.7M | 0.050% |
| Other reported values | 632 | $118.4M | 0.96% |
| Not reported | 316 | $54.5M | 0.44% |
Exact vehicle-match evidence
- VA FSS Schedule 65IB
66 awards · 14 matched parent PIIDs
Evidence: 36F79719D0169, 36F79719D0170, 36F79720D0099, 36F79722D0165, 36F79723D0158, …
$10.5M · 0.080%
Reported award data linked 66 awards to a specific catalog vehicle.
Offers, award size, and timing
- Median reported offers
- 1 median
- 821 reported · 297 not reported
- Positive award obligations
- $65K median
- $19K–$307K middle 50%
- Reported performance period
- 183 days (~6 months) median
- 1,117 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 158prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 97.6%of positive obligations in the last 12 months
- Leading four prime contractors
- 99.0%of positive obligations in the last 12 months
- Leading eight prime contractors
- 99.4%of positive obligations in the last 12 months
Based on $12.3B in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$12.0B
97.6%
Dollar movement
+$551.1M
vs. prior 12 months
Last 12mo awards
14 awards
15 actions
Historical and award details for MCKESSON CORPORATION
- Obligations: prior → latest
- $11.5B → $12.0B
- +4.8%
- Share: prior → latest
- 98.2% → 97.6%
- −0.6 percentage points
- All-period obligations
- $49.4B
- 97.8% of all-period positive obligations · 164 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 41 Not reported 11 12 Reported small business 0 0 All-period set-aside types
- 1 · Total small business
- #2
Last 12mo obligations
$105.1M
0.85%
Dollar movement
+$104.5M
vs. prior 12 months
Last 12mo awards
69 awards
107 actions
Historical and award details for EXELAN PHARMACEUTICALS INC
- Obligations: prior → latest
- $600K → $105.1M
- +17416.7%
- Share: prior → latest
- 0.010% → 0.85%
- +0.8 percentage points
- All-period obligations
- $109.1M
- 0.22% of all-period positive obligations · 97 awards
- Recorded activity
- Since Jun 21, 2022
- through Sep 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 7 0 Not reported 62 8 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$37.7M
0.31%
Dollar movement
+$5.6M
vs. prior 12 months
Last 12mo awards
71 awards
110 actions
Historical and award details for PROGENICS PHARMACEUTICALS INC
- Obligations: prior → latest
- $32.1M → $37.7M
- +17.5%
- Share: prior → latest
- 0.27% → 0.31%
- 0.0 percentage points
- All-period obligations
- $134.6M
- 0.27% of all-period positive obligations · 163 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 1, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 3 1 Reported no set-aside 0 3 Not reported 68 69 Reported small business 71 73 All-period set-aside types
- 7 · Total small business
- #4
Last 12mo obligations
$33.6M
0.27%
Dollar movement
+$25.8M
vs. prior 12 months
Last 12mo awards
40 awards
51 actions
Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
- Obligations: prior → latest
- $7.8M → $33.6M
- +331.3%
- Share: prior → latest
- 0.070% → 0.27%
- +0.2 percentage points
- All-period obligations
- $41.3M
- 0.080% of all-period positive obligations · 51 awards
- Recorded activity
- Since Oct 22, 2021
- through Aug 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 40 15 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$20.7M
0.17%
Dollar movement
−$4.6M
vs. prior 12 months
Last 12mo awards
124 awards
175 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $25.3M → $20.7M
- −18.3%
- Share: prior → latest
- 0.22% → 0.17%
- −0.1 percentage points
- All-period obligations
- $105.9M
- 0.21% of all-period positive obligations · 393 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 29 53 Not reported 95 85 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$8.5M
0.070%
Dollar movement
+$502K
vs. prior 12 months
Last 12mo awards
72 awards
81 actions
Historical and award details for BRISTOL-MYERS SQUIBB COMPANY
- Obligations: prior → latest
- $8.0M → $8.5M
- +6.3%
- Share: prior → latest
- 0.070% → 0.070%
- 0.0 percentage points
- All-period obligations
- $21.1M
- 0.040% of all-period positive obligations · 111 awards
- Recorded activity
- Since Mar 22, 2022
- through Sep 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 72 29 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$8.0M
0.070%
Dollar movement
+$2.9M
vs. prior 12 months
Last 12mo awards
31 awards
47 actions
Historical and award details for RLS (USA) INC.
- Obligations: prior → latest
- $5.1M → $8.0M
- +57.4%
- Share: prior → latest
- 0.040% → 0.070%
- 0.0 percentage points
- All-period obligations
- $22.0M
- 0.040% of all-period positive obligations · 61 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 1, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 4 4 Reported no set-aside 8 9 Not reported 19 16 Reported small business 24 25 All-period set-aside types
- 8 · Total small business
- #8
Last 12mo obligations
$6.6M
0.050%
Dollar movement
+$4.1M
vs. prior 12 months
Last 12mo awards
34 awards
59 actions
Historical and award details for PETNET SOLUTIONS, INC.
- Obligations: prior → latest
- $2.5M → $6.6M
- +164.0%
- Share: prior → latest
- 0.020% → 0.050%
- 0.0 percentage points
- All-period obligations
- $14.6M
- 0.030% of all-period positive obligations · 98 awards
- Recorded activity
- Since Oct 1, 2021
- through Aug 27, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 8 Not reported 21 23 Reported small business 5 11 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$6.6M
0.050%
Dollar movement
−$4.7M
vs. prior 12 months
Last 12mo awards
32 awards
69 actions
Historical and award details for SOFIE CO.
- Obligations: prior → latest
- $11.3M → $6.6M
- −41.5%
- Share: prior → latest
- 0.10% → 0.050%
- −0.1 percentage points
- All-period obligations
- $45.0M
- 0.090% of all-period positive obligations · 78 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 3 Reported no set-aside 13 16 Not reported 17 12 Reported small business 30 29 All-period set-aside types
- 8 · Total small business
- #10
Last 12mo obligations
$4.2M
0.030%
Dollar movement
+$2.9M
vs. prior 12 months
Last 12mo awards
6 awards
10 actions
Historical and award details for NUCLEAR DIAGNOSTIC PRODUCTS, INC
- Obligations: prior → latest
- $1.3M → $4.2M
- +220.9%
- Share: prior → latest
- 0.010% → 0.030%
- 0.0 percentage points
- All-period obligations
- $8.4M
- 0.020% of all-period positive obligations · 24 awards
- Recorded activity
- Since Oct 1, 2021
- through May 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 1 0 Reported no set-aside 2 3 Not reported 3 9 Reported small business 6 12 All-period set-aside types
- 2 · Total small business
- #11
Last 12mo obligations
$3.7M
0.030%
Dollar movement
+$427K
vs. prior 12 months
Last 12mo awards
14 awards
22 actions
Historical and award details for BRACCO DIAGNOSTICS INC.
- Obligations: prior → latest
- $3.3M → $3.7M
- +13.0%
- Share: prior → latest
- 0.030% → 0.030%
- 0.0 percentage points
- All-period obligations
- $14.5M
- 0.030% of all-period positive obligations · 33 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 30, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 2 Not reported 11 7 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$3.6M
0.030%
Dollar movement
+$353K
vs. prior 12 months
Last 12mo awards
64 awards
75 actions
Historical and award details for MEDI-PHYSICS, INC.
- Obligations: prior → latest
- $3.3M → $3.6M
- +10.8%
- Share: prior → latest
- 0.030% → 0.030%
- 0.0 percentage points
- All-period obligations
- $15.9M
- 0.030% of all-period positive obligations · 149 awards
- Recorded activity
- Since Oct 1, 2021
- through Aug 10, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 3 Not reported 61 45 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$3.4M
0.030%
Dollar movement
−$1.6M
vs. prior 12 months
Last 12mo awards
44 awards
60 actions
Historical and award details for JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.
- Obligations: prior → latest
- $5.1M → $3.4M
- −32.3%
- Share: prior → latest
- 0.040% → 0.030%
- 0.0 percentage points
- All-period obligations
- $17.0M
- 0.030% of all-period positive obligations · 71 awards
- Recorded activity
- Since Jan 28, 2022
- through Aug 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 1 Reported no set-aside 12 12 Not reported 32 22 Reported small business 16 11 All-period set-aside types
- 1 · Total small business
- #14
Last 12mo obligations
$3.2M
0.030%
Dollar movement
−$1.6M
vs. prior 12 months
Last 12mo awards
10 awards
12 actions
Historical and award details for PHARMACY BUYING ASSOCIATION, INC.
- Obligations: prior → latest
- $4.8M → $3.2M
- −33.1%
- Share: prior → latest
- 0.040% → 0.030%
- 0.0 percentage points
- All-period obligations
- $30.0M
- 0.060% of all-period positive obligations · 212 awards
- Recorded activity
- Since Oct 29, 2021
- through Jul 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 7 25 Reported no set-aside 3 9 Not reported 0 0 Reported small business 10 34 All-period set-aside types
- 131 · Total small business
- #15
Last 12mo obligations
$2.7M
0.020%
Dollar movement
+$2.7M
vs. prior 12 months
Last 12mo awards
11 awards
15 actions
Historical and award details for OPTUM INFUSION SERVICES 308, LLC
- Obligations: prior → latest
- $0 → $2.7M
- Not comparable
- Share: prior → latest
- 0% → 0.020%
- 0.0 percentage points
- All-period obligations
- $2.7M
- 0.010% of all-period positive obligations · 11 awards
- Recorded activity
- Since Oct 1, 2025
- through Aug 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 0 Not reported 8 0 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$1.4B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
Why it stands out
One action represented 11.4% of the market’s latest 12-month positive obligations.
At $1.4B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.4B
- Share of 12-month positive obligations
- 11.4%
Supporting data
- Prime contractor
- #1 · 97.6% share
- −0.6 percentage points · $551.1M net increase; action exceeded it by $855.7M
- Funding office
- #1 · 97.7% attributed share
- −0.5 percentage points · $551.8M net increase; action exceeded it by $855.1M
This action
+$1.4B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY
Why it stands out
One action represented 11.4% of the market’s latest 12-month positive obligations.
At $1.4B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.4B
- Share of 12-month positive obligations
- 11.4%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY
Why it stands out
One action represented 9.7% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.7%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE
Why it stands out
One action represented 9.7% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.7%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL
Why it stands out
One action represented 9.7% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.7%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
Why it stands out
One action represented 9.6% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.6%
View recent award activity by date (10)
- Action−$364KAward net obligations$0
- Action+$50KAward net obligations$50K
- Action+$23KAward net obligations$23K
- Action+$16KAward net obligations$16K
- Action−$213Award net obligations$358K
- Action−$7KAward net obligations$24K
- Action−$6KAward net obligations$29K
- Action−$582KAward net obligations$1.8M
- Action+$181KAward net obligations$1.5M
- Action+$72KAward net obligations$72K
VA pharmaceutical preparation manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top VA pharmaceutical preparation manufacturing contractors?
In the 12 months through September 10, 2026, MCKESSON CORPORATION, EXELAN PHARMACEUTICALS INC, and PROGENICS PHARMACEUTICALS INC were the leading VA pharmaceutical preparation manufacturing prime contractors by positive obligations.
- #1
$12,001,644,474 in positive obligations
- #2
$105,104,684 in positive obligations
- #3
$37,695,560 in positive obligations
Rankings use reported USAspending award data.
Did VA contract obligations increase in the pharmaceutical preparation manufacturing market?
Yes. Measured by net prime contract obligations, reported VA activity in the pharmaceutical preparation manufacturing market increased 5.3% from $11,663,017,284 in the preceding 12 months to $12,286,195,779 in the 12 months through September 10, 2026.
- Latest 12 months
- $12,286,195,779
- Net prime contract obligations
- Preceding 12 months
- $11,663,017,284
- Net prime contract obligations
- Change
- +5.3%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent VA contract award activity was reported in the pharmaceutical preparation manufacturing market?
Recent VA contract award activity reported in the pharmaceutical preparation manufacturing market included actions for MCKESSON CORPORATION during the 12 months through September 10, 2026.
-
MCKESSON CORPORATION · PIID 36C24026K1002
Base award · November 1, 2025 · Action obligation: +$1,406,868,182
-
MCKESSON CORPORATION · PIID 36C24026K1008
Base award · May 1, 2026 · Action obligation: +$1,398,025,092
-
MCKESSON CORPORATION · PIID 36C24026K1010
Base award · July 1, 2026 · Action obligation: +$1,194,619,137
-
MCKESSON CORPORATION · PIID 36C24026K1009
Base award · June 1, 2026 · Action obligation: +$1,191,973,258
-
MCKESSON CORPORATION · PIID 36C24026K1007
Base award · April 1, 2026 · Action obligation: +$1,191,348,081
-
MCKESSON CORPORATION · PIID 36C24026K1001
Base award · October 1, 2025 · Action obligation: +$1,184,200,532
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for VA contracts under NAICS 325412?
From September 11, 2025 through September 10, 2026, VA reported 1,118 positive-obligation awards for pharmaceutical preparation manufacturing under NAICS 325412. The leading award type was delivery order. The leading reported procedure was negotiated proposal/quote.
- Positive-obligation awards
- 1,118
- Leading reported procedure
- Negotiated Proposal/Quote
- 87.8% of positive obligations
- Leading award type
- Delivery Order
- 99.2% of positive obligations
- Full and open
- 89.2%
- of positive obligations
- Reported parent IDV
- 99.6%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology